Cargando…
Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young?
Small cell carcinoma of the ovary, hypercalcemic type is a rare, aggressive, and typically fatal ovarian cancer that primarily affects young women less than 40 years of age. It is caused by a pathogenic variant in the SMARCA4 gene, with nearly half of patients found to have germline pathogenic varia...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201186/ https://www.ncbi.nlm.nih.gov/pubmed/32382648 http://dx.doi.org/10.1016/j.gore.2020.100569 |
_version_ | 1783529494337814528 |
---|---|
author | Podwika, Sarah E. Jenkins, Taylor M. Khokhar, Joyti K. Erickson, Sarah H. Modesitt, Susan C. |
author_facet | Podwika, Sarah E. Jenkins, Taylor M. Khokhar, Joyti K. Erickson, Sarah H. Modesitt, Susan C. |
author_sort | Podwika, Sarah E. |
collection | PubMed |
description | Small cell carcinoma of the ovary, hypercalcemic type is a rare, aggressive, and typically fatal ovarian cancer that primarily affects young women less than 40 years of age. It is caused by a pathogenic variant in the SMARCA4 gene, with nearly half of patients found to have germline pathogenic variants and the remainder demonstrating somatic SMARCA4 pathogenic variants. This case report discusses an illustrative case and explores the existing data and potential recommendations to optimize timing of genetic testing in family members, given the presence of a familial germline pathogenic variant. |
format | Online Article Text |
id | pubmed-7201186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-72011862020-05-07 Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young? Podwika, Sarah E. Jenkins, Taylor M. Khokhar, Joyti K. Erickson, Sarah H. Modesitt, Susan C. Gynecol Oncol Rep Case Report Small cell carcinoma of the ovary, hypercalcemic type is a rare, aggressive, and typically fatal ovarian cancer that primarily affects young women less than 40 years of age. It is caused by a pathogenic variant in the SMARCA4 gene, with nearly half of patients found to have germline pathogenic variants and the remainder demonstrating somatic SMARCA4 pathogenic variants. This case report discusses an illustrative case and explores the existing data and potential recommendations to optimize timing of genetic testing in family members, given the presence of a familial germline pathogenic variant. Elsevier 2020-04-07 /pmc/articles/PMC7201186/ /pubmed/32382648 http://dx.doi.org/10.1016/j.gore.2020.100569 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Podwika, Sarah E. Jenkins, Taylor M. Khokhar, Joyti K. Erickson, Sarah H. Modesitt, Susan C. Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young? |
title | Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young? |
title_full | Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young? |
title_fullStr | Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young? |
title_full_unstemmed | Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young? |
title_short | Optimal age for genetic cancer predisposition testing in hereditary SMARCA4 Ovarian Cancer Families: How young is too young? |
title_sort | optimal age for genetic cancer predisposition testing in hereditary smarca4 ovarian cancer families: how young is too young? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201186/ https://www.ncbi.nlm.nih.gov/pubmed/32382648 http://dx.doi.org/10.1016/j.gore.2020.100569 |
work_keys_str_mv | AT podwikasarahe optimalageforgeneticcancerpredispositiontestinginhereditarysmarca4ovariancancerfamilieshowyoungistooyoung AT jenkinstaylorm optimalageforgeneticcancerpredispositiontestinginhereditarysmarca4ovariancancerfamilieshowyoungistooyoung AT khokharjoytik optimalageforgeneticcancerpredispositiontestinginhereditarysmarca4ovariancancerfamilieshowyoungistooyoung AT ericksonsarahh optimalageforgeneticcancerpredispositiontestinginhereditarysmarca4ovariancancerfamilieshowyoungistooyoung AT modesittsusanc optimalageforgeneticcancerpredispositiontestinginhereditarysmarca4ovariancancerfamilieshowyoungistooyoung |